Pyxis Oncology
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $11,038 | $0 | $2,820 | $0 |
Gross Profit | 11,470 | 0 | 2,820 | -552 |
EBITDA | -18,295 | -21,468 | -19,215 | -22,362 |
EBIT | -21,184 | -22,003 | -19,750 | -22,914 |
Net Income | -18,106 | -22,003 | -18,354 | -21,158 |
Net Change In Cash | 11,038 | 0 | 2,820 | 0 |
Free Cash Flow | -10,427 | -13,286 | -17,263 | -22,535 |
Cash | 15,422 | 10,391 | 10,733 | 12,759 |
Basic Shares | 62,143 | 62,557 | 61,918 | 61,048 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $13,858 | $16,146 | $0 | $0 |
Gross Profit | 11,470 | 15,671 | -2,000 | -1,836 |
EBITDA | -84,420 | -65,514 | -80,269 | -122,772 |
EBIT | -88,931 | -68,496 | -82,196 | -123,481 |
Net Income | -79,621 | -77,331 | -73,790 | -117,953 |
Net Change In Cash | 13,858 | 16,146 | 0 | 0 |
Cost of Revenue | -95,551 | |||
Free Cash Flow | -63,511 | -57,909 | -77,435 | -95,734 |
Cash | 15,422 | 19,473 | 9,664 | 179,293 |
Basic Shares | 62,143 | 58,445 | 39,904 | 33,033 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.29 |
2025-09-30 | -$0.35 |
2025-06-30 | -$0.30 |
